US export certificates guidance updates:
This article was originally published in Clinica
The US FDA has updated its 2002 guidance document on export certificates, which are often demanded by foreign governments to demonstrate that the product being exported can be marketed in the US or meets specific US regulations. The agency has the option of charging a fee of up to $175 if it issues a certificate within 20 government working days of receipt of a complete request for such a document.
You may also be interested in...
The Italian firm's move to license Isturisa from Novartis last year is paying dividends already and Recordati has already tripled its peak sales forecast for the Cushing's therapy.
Pfizer is up against AstraZeneca and Sanofi in developing competing approaches to tackling the unmet need in respiratory syncytial virus (RSV). But earlier failures mean all players will need much more data to sway regulators.
Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Fifty-two guidance documents have been posted on the tracker since its last update.